Evidence map›Paper›PMID 25381466›Full record

ArticleHuman genetics2015

Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition.

Gemma L Moir-Meyer, John F Pearson, Felicity Lose, Australian National Endometrial Cancer Study Group, Rodney J Scott, Mark McEvoy, John Attia, Elizabeth G Holliday, Hunter Community Study, Studies of Epidemiology and Risk Factors in Cancer Heredity and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Candidate predisposing germline copy number variants in early onset colorectal cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Gemma L Moir-MeyerMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand, gemma.moir-meyer@qimrberghofer.edu.au.
John F Pearson
Felicity Lose
Australian National Endometrial Cancer Study Group
Rodney J Scott
Mark McEvoy
John Attia
Elizabeth G Holliday
Hunter Community Study
Studies of Epidemiology and Risk Factors in Cancer Heredity
Paul D Pharoah
Alison M Dunning
Deborah J Thompson
Douglas F Easton
Amanda B Spurdle
Logan C Walker
University of Cambridge · GBQIMR Berghofer Medical Research Institute · AUJohn Hunter Hospital · AUUniversity of Otago · NZUniversity of Newcastle Australia · AU

Funding

Cancer Research UK 10124Cancer Research UK 16561Cancer Research UK 16563Cancer Research UK 16565Cancer Research UK C1287/A10118Cancer Research UK C490/A1021Cancer Research UK C8197/A10123Cancer Research UK C8197/A10865Wellcome Trust
6 · The paper itself

Abstract

Endometrial cancer is the most common invasive gynaecological cancer in women, and relatively little is known about inherited risk factors for this disease. This is the first genome-wide study to explore the role of common and rare germline copy number variants (CNVs) in predisposition to endometrial cancer. CNVs were called from germline DNA of 1,209 endometrioid endometrial cancer cases and 528 cancer-unaffected female controls. Overall CNV load of deletions or DNA gains did not differ significantly between cases and controls (P > 0.05), but cases presented with an excess of rare germline deletions overlapping likely functional genomic regions including genes (P = 8 × 10(-10)), CpG islands (P = 1 × 10(-7)) and sno/miRNAs regions (P = 3 × 10(-9)). On average, at least one additional gene and two additional CpG islands were disrupted by rare deletions in cases compared to controls. The most pronounced difference was that over 30 sno/miRNAs were disrupted by rare deletions in cases for every single disruption event in controls. A total of 13 DNA repair genes were disrupted by rare deletions in 19/1,209 cases (1.6%) compared to one gene in 1/528 controls (0.2%; P = 0.007), and this increased DNA repair gene loss in cases persisted after excluding five individuals carrying CNVs disrupting mismatch repair genes MLH1, MSH2 and MSH6 (P = 0.03). There were 34 miRNA regions deleted in at least one case but not in controls, the most frequent of which encompassed hsa-mir-661 and hsa-mir-203. Our study implicates rare germline deletions of functional and regulatory regions as possible mechanisms conferring endometrial cancer risk, and has identified specific regulatory elements as candidates for further investigation.

Indexed as

DNA Copy Number VariationsGerm-Line MutationSequence DeletionAgedAged, 80 and overCase-Control StudiesCpG IslandsDNA RepairEndometrial NeoplasmsFemaleGenes, NeoplasmGenetic Association StudiesGenetic Predisposition to DiseaseHumansMiddle AgedPolymorphism, Single Nucleotide

Identifiers

PMID25381466
OpenAlexW2091994514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.